Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yves Beguin

Showing results (141-150 of 243) with videos related to

Pageof 25
Sort By:
Oncoimmunology|June 23, 2017
Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effectsGrégory Ehx, Gilles Fransolet, Laurence de Leval, et al.
Annals of Hematology|September 8, 2014
Rituximab therapy for hairy cell leukemia: a retrospective study of 41 casesMathieu Leclerc, Felipe Suarez, Marie-Pierre Noël, et al.
Cytotherapy|December 26, 2012
Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host diseaseFrance Bruck, Ludovic Belle, Chantal Lechanteur, et al.
Haematologica|January 29, 2008
Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioningEmilie Castermans, Frédéric Baron, Evelyne Willems, et al.
American Journal of Hematology|July 23, 2013
Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trialYves Beguin, Johan Maertens, Bernard De Prijck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2018
In Vitro Th17-Polarized Human CD4<sup>+</sup> T Cells Exacerbate Xenogeneic Graft-versus-Host DiseaseLoïc Delens, Grégory Ehx, Joan Somja, et al.
Genes, Chromosomes & Cancer|July 26, 2016
Genomic studies of multiple myeloma reveal an association between X chromosome alterations and genomic profile complexityTiberio Sticca, Jean-Hubert Caberg, Stephane Wenric, et al.
Frontiers in Immunology|December 29, 2025
Development of a humanized mouse model of graft-versus-host disease to assess human regulatory T cell functionCharline Beguin, Oswin Kwan, Grégory Ehx, et al.
Hemasphere|June 26, 2023
Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple MyelomaMargaux Lejeune, Murat Cem Köse, Mégane Jassin, et al.
Transfusion|January 10, 2003
Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignanciesMarc André, Etienne Baudoux, Dominique Bron, et al.
Pageof 25

Showing results (141-150 of 243) with videos related to

Sort By:
Pageof 25
Oncoimmunology|June 23, 2017
Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effectsGrégory Ehx, Gilles Fransolet, Laurence de Leval, et al.
Annals of Hematology|September 8, 2014
Rituximab therapy for hairy cell leukemia: a retrospective study of 41 casesMathieu Leclerc, Felipe Suarez, Marie-Pierre Noël, et al.
Cytotherapy|December 26, 2012
Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host diseaseFrance Bruck, Ludovic Belle, Chantal Lechanteur, et al.
Haematologica|January 29, 2008
Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioningEmilie Castermans, Frédéric Baron, Evelyne Willems, et al.
American Journal of Hematology|July 23, 2013
Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation: a prospective multicenter randomized trialYves Beguin, Johan Maertens, Bernard De Prijck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 17, 2018
In Vitro Th17-Polarized Human CD4<sup>+</sup> T Cells Exacerbate Xenogeneic Graft-versus-Host DiseaseLoïc Delens, Grégory Ehx, Joan Somja, et al.
Genes, Chromosomes & Cancer|July 26, 2016
Genomic studies of multiple myeloma reveal an association between X chromosome alterations and genomic profile complexityTiberio Sticca, Jean-Hubert Caberg, Stephane Wenric, et al.
Frontiers in Immunology|December 29, 2025
Development of a humanized mouse model of graft-versus-host disease to assess human regulatory T cell functionCharline Beguin, Oswin Kwan, Grégory Ehx, et al.
Hemasphere|June 26, 2023
Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple MyelomaMargaux Lejeune, Murat Cem Köse, Mégane Jassin, et al.
Transfusion|January 10, 2003
Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignanciesMarc André, Etienne Baudoux, Dominique Bron, et al.
Pageof 25